Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Morphine antinociception is mediated through a LiCl-sensitive, IP3-restorable pathway.

R B Raffa1, R P Martinez

  • 1Drug Discovery Research, R. W. Johnson Pharmaceutical Research Institute, Spring House, PA 19477-0776.

European Journal of Pharmacology
|May 14, 1992
PubMed
Summary

Lithium chloride (LiCl) pretreatment reduced morphine

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Galcanezumab: a humanized monoclonal antibody for the prevention of migraine and cluster headache.

Drugs of today (Barcelona, Spain : 1998)·2020
Same author

Indirect-acting strategy of opioid action instead of direct receptor activation: dual-acting enkephalinase inhibitors (DENKIs).

Journal of clinical pharmacy and therapeutics·2018
Same author

Curcumin in turmeric: Basic and clinical evidence for a potential role in analgesia.

Journal of clinical pharmacy and therapeutics·2018
Same author

The role and mechanism of action of menthol in topical analgesic products.

Journal of clinical pharmacy and therapeutics·2018
Same author

Nature's first "atypical opioids": Kratom and mitragynines.

Journal of clinical pharmacy and therapeutics·2018
Same author

The rapid-onset antidepressant effect of ketamine: More surprises?

Journal of clinical pharmacy and therapeutics·2017

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Signaling

Background:

  • Opioid analgesia, particularly morphine's pain-relieving effects, is crucial in pain management.
  • Understanding the cellular mechanisms underlying morphine action is essential for optimizing pain therapies and mitigating tolerance.
  • Second messenger pathways play a significant role in modulating neuronal responses to drugs.

Purpose of the Study:

  • To investigate the role of lithium chloride (LiCl)-sensitive signaling pathways in mediating morphine-induced analgesia.
  • To explore the involvement of inositol-1,4,5-trisphosphate (IP3) in the antinociceptive effects of morphine.

Main Methods:

  • Mice were pretreated with LiCl or vehicle.
  • Antinociceptive effects of centrally administered morphine were assessed using the tail-flick test.

Related Experiment Videos

  • Inositol-1,4,5-trisphosphate (IP3) was coadministered with morphine in LiCl-pretreated mice.

    • Main Results:

    • LiCl pretreatment significantly reduced the antinociceptive efficacy of morphine in the tail-flick test.
    • Coadministration of IP3 with morphine restored morphine-induced antinociception in LiCl-pretreated mice.
    • These results indicate a LiCl-sensitive pathway, potentially involving phosphoinositides, in morphine analgesia.

    Conclusions:

    • A LiCl-sensitive second messenger pathway is implicated in the mechanism of morphine analgesia.
    • Inositol-1,4,5-trisphosphate (IP3) appears to play a role in restoring morphine's pain-relieving effects when this pathway is modulated.
    • These findings contribute to a deeper understanding of opioid signaling and may inform future analgesic drug development.